As filed with the Securities and Exchange Commission on April 22, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
SeaStar Medical Holding Corporation
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
001-39927 |
(State or other jurisdiction of |
|
(I.R.S. Employer |
|
|
|
3513 Brighton Blvd., Suite 410 Denver, CO |
|
80216 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Amended and Restated SeaStar Medical Holding Corporation 2022 Omnibus Incentive Plan
(Full title of the plan)
Eric Schlorff
Chief Executive Officer
3513 Brighton Blvd.
Suite 410
Denver, CO 80216
(Name and address of agent for service)
(844) 427-8100
(Telephone number, including area code, of agent for service)
With copies of all notices, orders, and communications to:
Joshua Erekson Daniel Lyman Dorsey & Whitney LLP 111 South Main Street, Suite 2100 Salt Lake City, UT 84111 (801) 933-7360 |
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
Large accelerated filer |
|
☐ |
|
Accelerated filer |
|
☐ |
Non-accelerated filer |
|
☒ |
|
Smaller reporting company |
|
☒ |
|
|
|
|
Emerging growth company |
|
☒ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 (the “Registration Statement”), relating to the SeaStar Medical Holding Corporation 2022 Omnibus Incentive Plan (as amended, the “Incentive Plan”), is being filed pursuant to General Instruction E to Form S-8, for the purpose of registering: (i) an aggregate of 260,000 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”) (after giving effect to the reverse stock split referenced below), of SeaStar Medical Holding Corporation (the “Registrant”), reserved for issuance pursuant to an amendment to the Incentive Plan, which was approved by shareholders on June 4, 2024, (ii) an aggregate of 212,456 Shares reserved for issuance pursuant to the evergreen provision of the Incentive Plan, under which the share reserve is automatically increased annually in accordance with the terms of the Incentive Plan and (iii) pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), any additional shares of Common Stock that become issuable under the Incentive Plan by reason of any stock dividend, stock split, or other similar transaction.
The Shares are securities of the same class and relate to the same employee benefit plan as the 50,800 shares of Common Stock (after giving effect to the reverse stock split referenced below) registered for issuance pursuant to the Registration Statement on Form S-8, File No. 333-270070, filed by the Registrant with the Securities and Exchange Commission (the “SEC”) on February 27, 2023 and the 47,200 shares of Common Stock (after giving effect to the reverse split referenced below) registered for issuance pursuant to the Registration Statement on Form S-8, File No. 333-276978, filed by the Registrant with the SEC on February 9, 2024 (collectively, the “Prior Registration Statements”). This Registration Statement is filed in accordance with General Instruction E to Form S-8. Accordingly, pursuant to General Instruction E, the Registrant hereby incorporates by reference herein the contents of the Prior Registration Statements and hereby deems such contents to be a part hereof, except as otherwise updated or modified by this Registration Statement.
All share amounts referenced above and otherwise in this Registration Statement give effect to a 1-for-25 reverse stock split of the Common Stock, which was effected on June 7, 2024.
PART II.
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents filed by the Registrant with the SEC pursuant to the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), are hereby incorporated by reference into this Registration Statement:
|
(a) |
The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 27, 2025; |
|
(b) |
The Registrant’s Current Reports on Form 8-K filed with the SEC on January 13, 2025 (except for Item 7.01 and any exhibits furnished under Item 7.01), January 31, 2025, February 3, 2025 (except for Item 7.01 and any exhibits furnished under Item 7.01), March 13, 2025, March 21, 2025; and March 28, 2025; and |
|
(c) |
The description of the Registrant’s Common Stock set forth in the Registrant’s registration statement on Form 8-A/A filed with the SEC on October 31, 2022, as updated by Exhibit 4.3 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 27, 2025, and any amendment or report filed with the SEC for the purposes of updating such description. |
All other reports and other documents subsequently filed with the SEC by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of Exchange Act prior to the filing of a post-effective amendment to this registration statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold (other than those furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K or other information deemed to have been “furnished” rather than “filed” in accordance with the SEC’s rules), shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such reports and documents.
Any statement contained in a document incorporated or deemed to be incorporated by reference in this Registration Statement shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained in this Registration Statement, or in any other subsequently filed document that also is or is deemed to be incorporated by reference in this Registration Statement, modifies or supersedes such prior statement. Any statement contained in this Registration Statement shall be deemed to be modified or superseded to the extent that a statement contained in a subsequently filed document that is or is deemed to be incorporated by reference in this Registration Statement modifies or supersedes such prior statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
Item 8. Exhibits.
A list of exhibits filed herewith is contained in the Exhibit Index that immediately precedes such exhibits and is incorporated herein by reference.
EXHIBIT INDEX
Exhibit |
Document |
||
|
|
||
|
|
||
|
|
||
|
|
||
4.4 |
|||
|
|
||
4.5 |
|||
|
|
||
|
|
|
|
Consent of WithumSmith+Brown, PC independent registered public accounting firm. |
|
|
|
|
|
||
23.2* |
Consent of Dorsey & Whitney LLP (included in Exhibit 5.1 hereto). |
|
|
|
|
||
Power of Attorney (included in the signature page to this Registration Statement). |
|
|
|
|
|
|
|
99.1*+ |
Amended and Restated SeaStar Medical Holding Corporation 2022 Omnibus Incentive Plan. |
||
|
|
||
107* |
Filing Fee Table. |
|
|
* Filed herewith
+ Denotes compensatory plan or arrangement
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Denver, State of Colorado on this 22nd day of April, 2025.
|
|
|
SeaStar Medical Holding Corporation |
||
|
|
|
By: |
|
/s/ Eric Schlorff |
Name: |
|
Eric Schlorff |
Title: |
|
Chief Executive Officer |
POWER OF ATTORNEY
Each of the undersigned, whose signature appears below, hereby constitutes and appoints Eric Schlorff as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments to this registration statement and to file the same with all exhibits thereto and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing necessary or appropriate to be done with respect to this registration statement or any amendments hereto in the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form S-8 has been signed by the following persons in the capacities indicated below on April 22, 2025.
Name |
Title |
Date |
|
|
|
/s/ Eric Schlorff |
Chief Executive Officer and Director (Principal Executive Officer) |
April 22, 2025 |
Eric Schlorff |
||
|
|
|
/s/ David Green |
Chief Financial Officer (Principal Financial and Accounting Officer) |
April 22, 2025 |
David Green |
||
|
|
|
/s/ Rick Barnett |
Chairman of the Board of Directors |
April 22, 2025 |
Rick Barnett |
|
|
|
|
|
/s/ Kenneth Van Heel |
Director |
April 22, 2025 |
Kenneth Van Heel |
|
|
|
|
|
/s/ Jennifer A. Baird |
Director |
April 22, 2025 |
Jennifer A. Baird |
|
|
|
|
|
/s/ John Neuman |
Director |
April 22, 2025 |
John Neuman |
|
|
|
|
|
/s/ Bernadette N. Vincent |
Director |
April 22, 2025 |
Bernadette N. Vincent |
|
|